These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17728165)

  • 1. Prediction of the 3-D structure of rat MrgA G protein-coupled receptor and identification of its binding site.
    Heo J; Vaidehi N; Wendel J; Goddard WA
    J Mol Graph Model; 2007 Nov; 26(4):800-12. PubMed ID: 17728165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. On the molecular discrimination between adenine and guanine by proteins.
    Nobeli I; Laskowski RA; Valdar WS; Thornton JM
    Nucleic Acids Res; 2001 Nov; 29(21):4294-309. PubMed ID: 11691917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasticity of the ligand binding pocket in the bitter taste receptor T2R7.
    Liu K; Jaggupilli A; Premnath D; Chelikani P
    Biochim Biophys Acta Biomembr; 2018 May; 1860(5):991-999. PubMed ID: 29355483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A; Wang XS; Joseph CG; Xiang Z; Bauzo RM; Scott JW; Sorensen NB; Shaw AM; Millard WJ; Richards NG; Haskell-Luevano C
    J Med Chem; 2004 Apr; 47(9):2194-207. PubMed ID: 15084118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of transmembrane domain 1 & 2 residues that contribute to the formation of the ligand-binding pocket of the urotensin-II receptor.
    Sainsily X; Cabana J; Holleran BJ; Escher E; Lavigne P; Leduc R
    Biochem Pharmacol; 2014 Nov; 92(2):280-8. PubMed ID: 25175740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monte Carlo loop refinement and virtual screening of the thyroid-stimulating hormone receptor transmembrane domain.
    Ali MR; Latif R; Davies TF; Mezei M
    J Biomol Struct Dyn; 2015; 33(5):1140-52. PubMed ID: 25012978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plausible interaction of an alpha-fetoprotein cyclopeptide with the G-protein-coupled receptor model GPR30: docking study by molecular dynamics simulated annealing.
    Hamza A; Sarma MH; Sarma RH
    J Biomol Struct Dyn; 2003 Jun; 20(6):751-8. PubMed ID: 12744705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Free fatty acid receptors: structural models and elucidation of ligand binding interactions.
    Tikhonova IG; Poerio E
    BMC Struct Biol; 2015 Sep; 15():16. PubMed ID: 26346819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
    Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
    Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the 3D structure of FMRF-amide neuropeptides bound to the mouse MrgC11 GPCR and experimental validation.
    Heo J; Han SK; Vaidehi N; Wendel J; Kekenes-Huskey P; Goddard WA
    Chembiochem; 2007 Sep; 8(13):1527-39. PubMed ID: 17647204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orphan G protein-coupled receptors MrgA1 and MrgC11 are distinctively activated by RF-amide-related peptides through the Galpha q/11 pathway.
    Han SK; Dong X; Hwang JI; Zylka MJ; Anderson DJ; Simon MI
    Proc Natl Acad Sci U S A; 2002 Nov; 99(23):14740-5. PubMed ID: 12397184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology model of the CB1 cannabinoid receptor: sites critical for nonclassical cannabinoid agonist interaction.
    Shim JY; Welsh WJ; Howlett AC
    Biopolymers; 2003; 71(2):169-89. PubMed ID: 12767117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling, substrate docking, and mutational analysis identify residues essential for the function and specificity of a eukaryotic purine-cytosine NCS1 transporter.
    Krypotou E; Kosti V; Amillis S; Myrianthopoulos V; Mikros E; Diallinas G
    J Biol Chem; 2012 Oct; 287(44):36792-803. PubMed ID: 22969088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acid derivatives as bitter taste receptor (T2R) blockers.
    Pydi SP; Sobotkiewicz T; Billakanti R; Bhullar RP; Loewen MC; Chelikani P
    J Biol Chem; 2014 Sep; 289(36):25054-66. PubMed ID: 25059668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predicted 3D structures of the human M1 muscarinic acetylcholine receptor with agonist or antagonist bound.
    Peng JY; Vaidehi N; Hall SE; Goddard WA
    ChemMedChem; 2006 Aug; 1(8):878-90. PubMed ID: 16902941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7TM Domain Structure of Adhesion GPCRs.
    de Graaf C; Nijmeijer S; Wolf S; Ernst OP
    Handb Exp Pharmacol; 2016; 234():43-66. PubMed ID: 27832483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the adenine binding site of the human A1 adenosine receptor.
    Rivkees SA; Barbhaiya H; IJzerman AP
    J Biol Chem; 1999 Feb; 274(6):3617-21. PubMed ID: 9920910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying conformational changes in GPCRs: glimpse of a common functional mechanism.
    Dalton JA; Lans I; Giraldo J
    BMC Bioinformatics; 2015 Apr; 16(1):124. PubMed ID: 25902715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners.
    Paoletta S; Tosh DK; Salvemini D; Jacobson KA
    PLoS One; 2014; 9(5):e97858. PubMed ID: 24859150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.